Market Analysis — HURLEY MEDICAL CENTER
MI market | 4 hospitals | HHI: 3,264 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
4
Hospitals in Market
1,004
Total Beds
$1.2B
Market Revenue
Concentrated
HHI: 3,264
Narrow
Moat Rating (6/10)
#2
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantagemoderate
Switching Costshigh
Market Share32.2%
Top 3 Concentration98.6%
Network Density0.40
Margin vs Market+1.0%
Bed Util vs Market+2.7%
What This Means
This hospital has a narrow moat — narrow moat — some competitive advantages, but vulnerable to new entrants. The MI market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 3,264).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full MI market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| MCLAREN FLINT | 276 | $443M | 36.5% | 27.5% |
| GENESYS REGIONAL MEDICAL CTR. | 333 | $363M | 29.9% | 33.2% |
| SSH - FLINT INC | 26 | $17M | 1.4% | 2.6% |
Regional Payer Mix
■ Medicare 27%■ Medicaid 3%■ Commercial 70%